SANDRA PALMER: Open Payments
NPI 1316931249 · HARTFORD, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$332 in 14 payments from 10 companies in 2025. Trend: 2023 $1,809 · 2024 $515 · 2025 $332
Food & beverage: $332
| Company | Payments | Amount |
|---|---|---|
| Sumitomo Pharma America, Inc. | 3 | $66 |
| Intercept Pharmaceuticals, Inc. | 2 | $54 |
| Merck Sharp & Dohme LLC | 2 | $46 |
| Calyxo, Inc. | 1 | $37 |
| TOLMAR, INC. | 1 | $31 |
| Endo USA, Inc. | 1 | $26 |
| Astellas Pharma US Inc | 1 | $24 |
| EVOKE PHARMA, INC. | 1 | $18 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $17 |
| Boston Scientific Corporation | 1 | $12 |
Products named: GEMTESA, OCALIVA, LYNPARZA, CVAC ASPIRATION SYSTEM, JATENZO, AVEED, Xtandi, GIMOTI.
Industry payments across CT — which companies pay providers there.
